Total Funding
87
69
Total FundingSeed raised
Growth Score
4 pts
Heat Score
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
26360
Armatus Bio is an emerging precision therapeutics company at the intersection of genetic science and bioengineering.
- Michael Triplett: Co-Founder, President & CEOPast Role: Myonexus Therapeutics, Co-Founder & CEO
- Michael Triplett: Co-Founder, President & CEOPast Role: Myonexus Therapeutics, Co-Founder & CEO
About the Company
Armatus Bio is a new precision pharmaceutical firm based on genetic science and bioengineering. Precision therapeutics are being developed with dynamic thinking and rigorous processes to deliver life-saving drugs more effectively and efficiently than ever before. They believe that engineering will be a major catalyst in moving precision treatments
from research and development to mainstream care. To stimulate disruptive therapeutic innovation, they are using advanced engineering methodologies to create synergistic technologies.
